Lv2
110 积分 2021-05-26 加入
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
Patritumab Deruxtecan in Untreated Hormone Receptor–Positive/HER2-Negative Early Breast Cancer: Final Results from Part A of the Window-of-Opportunity SOLTI TOT-HER3 Pre-Operative Study
1年前
已关闭
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
1年前
已完结
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
1年前
已完结
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
1年前
已完结
The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience
1年前
已完结
SHP2 : The protein tyrosine phosphatase involved in chronic pulmonary inflammation and fibrosis
2年前
已完结
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
2年前
已完结
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
2年前
已关闭
Neoadjuvant Endocrine Therapy in Clinical Practice
2年前
已完结
皖公网安备34019202002308
